Stocktoria

NANOVIRICIDES, INC. NNVC

NYSE · stock · Pharmaceutical Preparations · website · IPO 2004-08-12 · LEI

NANOVIRICIDES, INC. statistics & valuation

Market cap$31.5M
P / B3.6×
Return on equity-94.7%
Return on capital-95.7%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2017201820192020202120222023202420252026
Operating margin (%)
2017201820192020202120222023202420252026
Return on equity (%)
-50.70% -48.50% -79.50% -61.80% -29.50% -35.10% -57.80% -72.30% -125.90% -94.70% 2017201820192020202120222023202420252026
Shares outstanding
63.3M 69.2M 3.8M 9.1M 11.5M 11.6M 11.7M 13.1M 16.6M 23.0M 2017201820192020202120222023202420252026
Net debt ($)
2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-38.20% -46.20% -62.60% -56.20% -29.20% -34.50% -50.80% -64.70% -107.30% -83.20% 2017201820192020202120222023202420252026
Free cash flow margin (%)
2017201820192020202120222023202420252026
Debt / equity (×)
2017201820192020202120222023202420252026
EPS ($)
-$0.17 -$0.13 -$0.81 -$0.70 -$0.74 -$0.70 -$0.63 -$0.41 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Return on assets-83.2%-107.3%-64.7%-50.8%-34.5%-29.2%-56.2%-62.6%-46.2%-38.2%
Return on equity-94.7%-125.9%-72.3%-57.8%-35.1%-29.5%-61.8%-79.5%-48.5%-50.7%
Current ratio2.661.283.6615.8134.9259.306.490.998.303.28

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.